Global Novel Drug Delivery Systems (NDDS) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022, the Novel Drug Delivery Systems (NDDS) market was valued at USD 165.4 Bn and is expected to reach USD 202.5 Bn by 2022, expanding at a CAGR of 2.7% from 2016 to 2022.
Browse Full Report Visit - http://www.acutemarketreports.com/report/novel-drug-delivery-systems--ndds--market
Market Insights
The novel drug delivery system (NDDS) provides a therapeutic amount of drug to the specific site in the body to accomplish promptly and then maintain the desired drug concentration. The drug- delivery system should deliver drug at a rate control by the necessarily of the body over a specified term of treatment. Market experts suggest that, There is a continuous growth in the market of drug delivery systems and will continue to grow at an impressive rate in future also. The novel drug delivery technologies enable to formulate the novel drug delivery devices by incorporating the drug molecules into new delivery systems, thus providing numerous therapeutic and commercial advantages. It was observed that NDDS market was segmented on the basis of route of administration, type of carrier and geographical region. In route of administration segment, injectable drug delivery system was observed as the largest market in 2015 followed by oral drug delivery system. Injectable drug delivery system comprises of several benefits over other dosage forms in cases such as unconsciousness, nausea, in emergency clinical episodes. The injectable administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. On the basis of type of carrier, liposomes and microspheres collectively attribute the largest share in the market in terms of revenue (USD). The key factors assisting the growth of liposomes market are such as, biologically active materials encapsulated within liposomes are protected to varying extent from immediate dilution or degradation which assists drug carrier systems for the transport of drugs and other bioactive capsules to disease-affected organs
Market Competition Assessment:
The key players involved in the novel drug delivery systems (NDDS) market are 3M Company, Abbott Laboratories Ltd., Amgen Inc., AstraZeneca Plc, Bausch & Lomb, Baxter International Inc., Bayer AG, Boehringer Ingelheim, Boston Scientific, Bristolmyers Squibb, Celgene Corporation, Cephalon, Inc., Genentech Inc., Genzyme Corporation, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Ltd.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/market-research
Key Market Movements:
• North America is expected to lead the global novel drug delivery systems market due to high disposable income, increasing research and development activities associated with development of drug delivery systems, high adoption rate of novel technologies and supportive reimbursement policies.
• Projected market entry of several products and technologies during 2016 to 2022 in global novel drug delivery systems market are expected to provide an exceptional growth to the market
• Novel drug delivery systems market is expected to intensify the market competition, ignition of price wars, and drive emphasis towards geographical expansion and penetration strategies to sustain in the competition
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Novel Drug Delivery Systems Market, by Route of Administration Type, 2016 - 2022 (USD Million)
2.2 Novel Drug Delivery Systems Market Share, by Carrier Type, 2022 (Value %)
2.3 Novel Drug Delivery Systems Market Share, by Geography, 2022 (Value %)
Chapter 3 Novel Drug Delivery Systems: Market Dynamics and Outlook
3.1 Introduction and Key Statistics
3.2 Novel Drug Delivery System: Current and Future Trends
3.3 Market Inclination Insights
3.4 Major Commercial Events
3.5 Market Dynamics
3.5.1 Drivers
3.5.2 Challenges
3.5.3 Opportunities
3.6 Porter's Five Forces Model
3.7 Attractive Investment Proposition
3.8 Market Positioning of Key Manufacturers
Chapter 4 Global Novel Drug Delivery Systems Market, by Route of Administration Type
4.1 Preface
4.2 Oral Drug Delivery Systems
4.3 Injectable Drug Delivery Systems
4.4 Pulmonary Drug Delivery Systems
4.5 Transdermal Drug Delivery Systems
4.6 Other Drug Delivery Systems
Chapter 5 Global Novel Drug Delivery System Market, By Carrier Type
5.1 Preface
5.2 Liposomes
5.3 Nanoparticles
5.4 Microspheres
5.5 Monoclonal antibodies
5.6 Others (Niosomes and Resealed erythrocytes as drug carriers)
To Get Complete Report @ http://www.acutemarketreports.com/report/novel-drug-delivery-systems--ndds--market
Chapter 6 Global Novel Drug Delivery System Market, By Geography
6.1 Preface
6.2 North America
6.2.1 US
6.3.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia Pacific
6.5 Latin America
6.6 Middle East and Africa
Chapter 7 Company Profiles
7.1 3M Company
7.2 Abbott Laboratories Ltd.
7.3 Amgen Inc.
7.4 Astrazeneca Plc
7.5 Bayer AG
7.6 Boehringer Ingelheim
7.7 Celgene Corporation
7.8 Genentech Inc.
7.9 Genzyme Corporation
7.10 Glaxosmithkline Plc
7.11 Merck & Co.
Browse Full Report Visit - http://www.acutemarketreports.com/report/novel-drug-delivery-systems--ndds--market
Market Insights
The novel drug delivery system (NDDS) provides a therapeutic amount of drug to the specific site in the body to accomplish promptly and then maintain the desired drug concentration. The drug- delivery system should deliver drug at a rate control by the necessarily of the body over a specified term of treatment. Market experts suggest that, There is a continuous growth in the market of drug delivery systems and will continue to grow at an impressive rate in future also. The novel drug delivery technologies enable to formulate the novel drug delivery devices by incorporating the drug molecules into new delivery systems, thus providing numerous therapeutic and commercial advantages. It was observed that NDDS market was segmented on the basis of route of administration, type of carrier and geographical region. In route of administration segment, injectable drug delivery system was observed as the largest market in 2015 followed by oral drug delivery system. Injectable drug delivery system comprises of several benefits over other dosage forms in cases such as unconsciousness, nausea, in emergency clinical episodes. The injectable administration route is the most common and efficient for delivery of active drug substances with poor bio-availability and the drugs with a narrow therapeutic index. On the basis of type of carrier, liposomes and microspheres collectively attribute the largest share in the market in terms of revenue (USD). The key factors assisting the growth of liposomes market are such as, biologically active materials encapsulated within liposomes are protected to varying extent from immediate dilution or degradation which assists drug carrier systems for the transport of drugs and other bioactive capsules to disease-affected organs
Market Competition Assessment:
The key players involved in the novel drug delivery systems (NDDS) market are 3M Company, Abbott Laboratories Ltd., Amgen Inc., AstraZeneca Plc, Bausch & Lomb, Baxter International Inc., Bayer AG, Boehringer Ingelheim, Boston Scientific, Bristolmyers Squibb, Celgene Corporation, Cephalon, Inc., Genentech Inc., Genzyme Corporation, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi SA, and Teva Pharmaceutical Industries Ltd.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/market-research
Key Market Movements:
• North America is expected to lead the global novel drug delivery systems market due to high disposable income, increasing research and development activities associated with development of drug delivery systems, high adoption rate of novel technologies and supportive reimbursement policies.
• Projected market entry of several products and technologies during 2016 to 2022 in global novel drug delivery systems market are expected to provide an exceptional growth to the market
• Novel drug delivery systems market is expected to intensify the market competition, ignition of price wars, and drive emphasis towards geographical expansion and penetration strategies to sustain in the competition
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Novel Drug Delivery Systems Market, by Route of Administration Type, 2016 - 2022 (USD Million)
2.2 Novel Drug Delivery Systems Market Share, by Carrier Type, 2022 (Value %)
2.3 Novel Drug Delivery Systems Market Share, by Geography, 2022 (Value %)
Chapter 3 Novel Drug Delivery Systems: Market Dynamics and Outlook
3.1 Introduction and Key Statistics
3.2 Novel Drug Delivery System: Current and Future Trends
3.3 Market Inclination Insights
3.4 Major Commercial Events
3.5 Market Dynamics
3.5.1 Drivers
3.5.2 Challenges
3.5.3 Opportunities
3.6 Porter's Five Forces Model
3.7 Attractive Investment Proposition
3.8 Market Positioning of Key Manufacturers
Chapter 4 Global Novel Drug Delivery Systems Market, by Route of Administration Type
4.1 Preface
4.2 Oral Drug Delivery Systems
4.3 Injectable Drug Delivery Systems
4.4 Pulmonary Drug Delivery Systems
4.5 Transdermal Drug Delivery Systems
4.6 Other Drug Delivery Systems
Chapter 5 Global Novel Drug Delivery System Market, By Carrier Type
5.1 Preface
5.2 Liposomes
5.3 Nanoparticles
5.4 Microspheres
5.5 Monoclonal antibodies
5.6 Others (Niosomes and Resealed erythrocytes as drug carriers)
To Get Complete Report @ http://www.acutemarketreports.com/report/novel-drug-delivery-systems--ndds--market
Chapter 6 Global Novel Drug Delivery System Market, By Geography
6.1 Preface
6.2 North America
6.2.1 US
6.3.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia Pacific
6.5 Latin America
6.6 Middle East and Africa
Chapter 7 Company Profiles
7.1 3M Company
7.2 Abbott Laboratories Ltd.
7.3 Amgen Inc.
7.4 Astrazeneca Plc
7.5 Bayer AG
7.6 Boehringer Ingelheim
7.7 Celgene Corporation
7.8 Genentech Inc.
7.9 Genzyme Corporation
7.10 Glaxosmithkline Plc
7.11 Merck & Co.
Latest Reports :
http://www.newzmarket.com/2017/07/14/latest-biosensor-will-recognize-dengue-on-initial-stage/
http://www.newzmarket.com/2017/07/14/latest-biosensor-will-recognize-dengue-on-initial-stage/
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
Our Blog :- http://www.pdfdevices.com/
